技术指标
指标
数值
方向
MACD(12,26,9)
-0.308
中性
RSI(14)
45.637
中性
STOCH(KDJ)(9,3,3)
40.641
买入
ATR(14)
0.638
低波动
CCI(14)
-48.609
中性
Williams %R
77.826
卖出
TRIX(12,20)
-0.131
卖出
StochRSI(14)
50.233
卖出
搜索
Schrodinger Inc
SDGR添加自选
15.140USD
-0.150-0.98%
收盘 07-29 16:00（美东）报价延迟15分钟
1.13B总市值
亏损市盈率 TTM
关键数据
15.220今开
15.410最高
662.04K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.89%换手率
15.290昨收
14.945最低
7.79M成交额
亏损市盈率静
3.60市净率
0.00%股息率 TTM
-15.03%ROA
27.63052周最高
0.94量比
-187.12M净利润
74.55M总股本
-1.3987每股收益TTM
1.61Beta
-30.12%ROE
10.94552周最低
3.04%振幅
50.43%毛利率
1.13B总市值
-1.91回报/风险
3.09%风险率
TradingKey Schrodinger Inc股票评分
单位: USD 更新时间: 2026-07-29操作建议
Schrodinger Inc当前公司基本面数据相对非常健康，增长潜力较大。当前估值合理，在软件与IT服务行业排名76/485位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价19.00。中期看，股价处于上升通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Schrodinger Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Schrodinger Inc亮点
亮点风险
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
业绩高增长
公司营业收入稳步增长，连续3年增长18.09%
估值低估
公司最新PE估值-10.81，处于3年历史低位
机构减仓
最新机构持股71.93M股，环比减少9.13%
比尔·盖茨持仓
明星投资者比尔·盖茨持仓，最新持仓市值13.85M
分析师目标
根据
7
位分析师
买入
评级
19.000
目标均价
+24.35%
涨幅空间
收益预测
分析师评级
根据
7
位分析师
买入
评级
19.000
目标均价
+24.35%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
221
总数
8
中位数
13
平均值
公司名称
评级分布
分析师数
Schrodinger Inc
SDGR
7
微软
MSFT
60
派拓网络
PANW
57
CrowdStrike Holdings Inc
CRWD
55
现在服务公司
NOW
50
Datadog Inc
DDOG
50
1
2
3
...
44
技术指标
移动平均线
指标
数值
方向
MA5
15.158
卖出
MA10
15.184
卖出
MA20
15.839
卖出
MA50
15.130
买入
MA100
13.631
买入
MA200
15.284
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Schrodinger Inc简介
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
公司代码SDGR
公司Schrodinger Inc
CEOFarid (Ramy Farid)
网址https://www.schrodinger.com
公司股东
相关品种
热门品种
常见问题
Schrodinger Inc(SDGR)的当前股价是多少？
Schrodinger Inc(SDGR)的当前股价是 15.14。
Schrodinger Inc的股票代码是什么？
Schrodinger Inc的股票代码是SDGR。
Schrodinger Inc股票的52周最高点是多少？
Schrodinger Inc股票的52周最高点是27.63。
Schrodinger Inc股票的52周最低点是多少？
Schrodinger Inc股票的52周最低点是10.95。
Schrodinger Inc的市值是多少？
Schrodinger Inc的市值是1.13B。
现在Schrodinger Inc(SDGR)的股票是买入、持有还是卖出？
根据分析师评级，Schrodinger Inc(SDGR)的总体评级为买入，目标价格为19.00。
Schrodinger Inc(SDGR)股票的每股收益（EPS TTM）是多少
Schrodinger Inc(SDGR)股票的每股收益（EPS TTM）是-1.41。